EpirubicinEpirubicin is used in the treatment of a range of neoplastic conditions including:
− Carcinoma of the breast
− Advanced ovarian cancer
− Gastric cancer
− Small cell lung cancer
When administered intravesically, epirubicin has been shown to be beneficial in the treatment of:
− Papillary transitional cell carcinoma of the bladder
− Carcinoma-in-situ of the bladder
− Intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection.

View the SPC...

Download the Epirubicin SPC. You will need Adobe Reader to view this document.

Get "spc-epirubicin-hydrochloride-2mgml-06_2016.pdf"...


Medicines Information Request

Click here to fill in a medicines information form about this product